Cargando…
Omega-3 fatty acids in heart disease—why accurately measured levels matter
Current guidelines barely support marine omega‑3 fatty acids eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) in cardiology, mainly because results of large trials were equivocal. Most large trials have tested EPA alone or EPA + DHA combined as a drug, thereby disregarding the relevance of...
Autores principales: | von Schacky, C., Kuipers, R. S., Pijl, H., Muskiet, F. A. J., Grobbee, D. E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bohn Stafleu van Loghum
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10602979/ https://www.ncbi.nlm.nih.gov/pubmed/36795219 http://dx.doi.org/10.1007/s12471-023-01759-2 |
Ejemplares similares
-
Omega-3 Fatty Acids in Pregnancy—The Case for a Target Omega-3 Index
por: von Schacky, Clemens
Publicado: (2020) -
Omega-3 Fatty Acids: Anti-Arrhythmic, Pro-Arrhythmic, or Both?
por: von Schacky, C.
Publicado: (2012) -
Omega-3 fatty acids in bipolar patients with a low omega-3 index and reduced heart rate variability: the “BIPO-3” trial
por: Berger, Michael, et al.
Publicado: (2022) -
Bioavailability of Dietary Omega-3 Fatty Acids Added to a Variety of Sausages in Healthy Individuals
por: Köhler, Anton, et al.
Publicado: (2017) -
Discrepancy between Knowledge and Perceptions of Dietary Omega-3 Fatty Acid Intake Compared with the Omega-3 Index
por: Thuppal, Sowmyanarayanan V., et al.
Publicado: (2017)